Ramirez Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ramirez Asset Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.2K	Buy	+191	New	+$19.6K	﹤0.01%	324

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Foundations Investment Advisors Phoenix, Arizona $10.1B AUM 19.55% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $32.8B AUM 18.62% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Horizon Investments Charlotte, North Carolina $11.6B AUM 26.87% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Ramirez Asset Management's IHE Position: Q3 2026 in Review

Ramirez Asset Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 191 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #324 among its holdings.

211 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Ramirez Asset Management held 191 shares of iShares US Pharmaceuticals ETF worth $19.2K as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Ramirez Asset Management position in Q3 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Ramirez Asset Management's portfolio in Q3 2026, its #324 holding.
211 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Ramirez Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.